Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 1/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | MYC | P01106 | 1/20 | 0.48 |
| ▸ | MAX | P61244 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 3/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.46 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17680606 | 0.82 | NPSR1 (0.59) | GRM5F2MYCMAXMTOR | |
| SCHEMBL2293623 | 0.79 | ALDH1A1 (0.63) | GRM5F2MTORHDAC1HDAC2 | |
| SCHEMBL17018687 | 0.79 | SLC1A2 (0.41) | MEN1KMT2ASLC1A2NPSR1KDM4E | |
| SCHEMBL17018685 | 0.79 | PKM (0.43) | MEN1KMT2ASLC1A2NPSR1KDM4E | |
| SCHEMBL14725928 | 0.78 | MTOR (0.48) | GRM5F2MYCMAXMTOR | |
| SCHEMBL11524926 | 0.77 | KDM4E (0.62) | GRM5F2MTORHDAC1HDAC2 | |
| SCHEMBL2623649 | 0.77 | ATM (0.51) | GRM5MYCMAXMTORHDAC1 | |
| SCHEMBL27529872 | 0.77 | SLC1A2 (0.63) | HDAC1HDAC2KMT2AMAPTSLC1A2 | |
| SCHEMBL3673898 | 0.76 | KCNK3 (0.61) | GRM5F2HDAC1HDAC2MEN1 | |
| SCHEMBL1926964 | 0.76 | MTOR (0.52) | GRM5F2MYCMAXMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150231284-A1 | MOLECULAR PROBE FOR IMAGING OF PANCREATIC ISLET AND THE PRECURSOR, AND USE OF THE SAME | ARKRAY, INC. (JP) | 2015-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150231284-A1 | MOLECULAR PROBE FOR IMAGING OF PANCREATIC ISLET AND THE PRECURSOR, AND USE OF THE SAME | IAPP, PDXK, NLK | GRM5 3248/4885F2 2390/4885MYC 4019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.